Bell Investment Advisors’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.72K Sell
25
-27
-52% -$6.05K ﹤0.01% 907
2025
Q4
$11.1K Sell
52
-1
-2% -$207 ﹤0.01% 654
2025
Q3
$10.5K Sell
53
-1
-2% -$187 ﹤0.01% 626
2025
Q2
$9.32K Buy
54
+10
+23% +$1.63K ﹤0.01% 699
2025
Q1
$6.86K Hold
44
﹤0.01% 763
2024
Q4
$6.06K Sell
44
-13
-23% -$1.71K ﹤0.01% 834
2024
Q3
$8.51K Buy
57
+5
+10% +$675 ﹤0.01% 683
2024
Q2
$7.09K Buy
52
+5
+11% +$680 ﹤0.01% 756
2024
Q1
$7.11K Buy
47
+4
+9% +$571 ﹤0.01% 731
2023
Q4
$5.42K Buy
43
+1
+2% +$100 ﹤0.01% 836
2023
Q3
$3.93K Buy
42
+10
+31% +$936 ﹤0.01% 936
2023
Q2
$2.86K Buy
32
+16
+100% +$1.39K ﹤0.01% 1117
2023
Q1
$1.72K Sell
16
-31
-66% -$3.55K ﹤0.01% 1339
2022
Q4
$5.74K Hold
47
﹤0.01% 739
2022
Q3
$5K Buy
47
+4
+9% +$379 ﹤0.01% 644
2022
Q2
$4K Buy
+43
New +$4.05K ﹤0.01% 766
2021
Q4
$5K Buy
35
+30
+600% +$4.46K ﹤0.01% 734
2021
Q3
$1K Buy
+5
New +$684 ﹤0.01% 1262

Other funds holding ASND